Fox Chase Cancer Center
Thoracic Malignancies: A Review of the Latest Evidence
Fox Chase Cancer Center
Thoracic Malignancies From an Interventional Pulmonologist's Perspective
FEATURING
Christopher Manley
- 316 views
- January 9, 2025
- 4
Fox Chase Cancer Center
Candidates for Surgical Resection in Lung Cancer: Criteria and Considerations
FEATURING
Stacey Su
- 38 views
- January 8, 2025
- 1
Fox Chase Cancer Center
Surgical Approaches After Neoadjuvant Treatment in Lung Cancer
FEATURING
Stacey Su
- 35 views
- January 8, 2025
- 1
Fox Chase Cancer Center
Role of Radiation in the Management of Oligoprogressive NSCLC
FEATURING
Randi Cohen
- 15 views
- January 8, 2025
Fox Chase Cancer Center
Adjuvant & Neoadjuvant Therapy in Early NSCLC With Actionable Genomic Alterations
FEATURING
Joshua Reuss
- 291 views
- January 8, 2025
- 3
Fox Chase Cancer Center
Nodules and Lung Cancer Screening
FEATURING
Rohit Kumar
- 512 views
- January 5, 2025
- 4
Fox Chase Cancer Center
2L Treatment Options for R/R SCLC
FEATURING
Parth Desai
- 41 views
- January 5, 2025
- 1
Fox Chase Cancer Center
IO Advances in Metastatic NSCLC Treatment
FEATURING
Hossein Borghaei
- 272 views
- January 2, 2025
- 5
Fox Chase Cancer Center
Unresectable Stage 3 NSCLC: Patient Selection and Treatment Options
FEATURING
Charu Aggarwal
- 190 views
- January 2, 2025
- 2
Fox Chase Cancer Center
1L IO Advances in ES-SCLC Treatment
FEATURING
Anne Chiang
- 232 views
- January 2, 2025
- 5
Fox Chase Cancer Center
Special Populations in Lung Cancer: KRAS, STK11, and KEAP1 Mutations and IO
FEATURING
Suki Padda
- 14 views
- December 16, 2024
Fox Chase Cancer Center
EGFR Mutations in NSCLC: Latest Updates and Key Changes
FEATURING
Joseph Bodor
- 140 views
- December 16, 2024
- 2
Fox Chase Cancer Center
Progress in Targeting ALK and ROS1 in NSCLC
FEATURING
Melina Marmarelis
- 72 views
- December 16, 2024